Download Unicorn Signals App

Powered By EquityPandit
Latest News

USFDA completes Unichem’s Ghaziabad plant inspection

The US health regulator has completed the inspection of Unichem’s Laboratories, Ghaziabad facility in Uttar Pradesh and the regulator has not issued any observation to it.

In a BSE filing it stated that, the company’s formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from April 16, 2018 to April 20,2018. The inspection was completed with zero observations.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile